Month: February 2021

Feb 20 2021

Uncategorized

Schizophrenia Pipeline: Analysis of 90+ key pipeline therapies, 90+ key pharma competitors, unmet needs, and opportunities – GlobeNewswire

by Clinical Editor

No Comments

Schizophrenia Pipeline: Analysis of 90+ key pipeline therapies, 90+ key pharma competitors, unmet needs, and opportunities  GlobeNewswire

Feb 20 2021

Uncategorized

Schizophrenia-associated SLC39A8 polymorphism is a loss-of-function allele altering glutamate receptor and innate immune signaling

by Clinical Editor

No Comments

Schizophrenia is a complex and heterogenous disease that presents with abnormalities in glutamate signaling and altered immune and inflammatory signals. Genome-wide association studies have indicated …

Feb 20 2021

Uncategorized

A unique missense variant in the E1A-binding protein P400 gene is implicated in schizophrenia by whole-exome sequencing and mutant mouse models

by Clinical Editor

No Comments

This study used whole-exome sequencing to investigate potential novel schizophrenia-causing genes in a Japanese family containing several members affected by severe or treatment-resistant …

Feb 20 2021

Uncategorized

Woman with schizophrenia shows signs of recovery after receiving help from ‘I-Witness’

by Clinical Editor

No Comments

A woman with schizophrenia is finally showing signs of recovery after getting featured and receiving help from “I-Witness.” …

Feb 20 2021

Uncategorized

New correlation between metabolic syndrome and schizophrenia

by Clinical Editor

No Comments

Medics have been seeking to understand why schizophrenia and bipolar disorder patients, prescribed antipsychotic medications, often rapidly gain weight (which can lead to prediabetes). New research …

Feb 20 2021

Uncategorized

Placenta’s Role in Schizophrenia ‘Bigger Than We Imagined’

by Clinical Editor

No Comments

Schizophrenia-related genes in the placenta, coupled with a complicated pregnancy, may alter baby’s brain growth and raise the risk for schizophrenia.

Feb 19 2021

Uncategorized

Schizophrenia-associated SLC39A8 polymorphism is a loss-of-function allele altering glutamate receptor and innate immune signaling

by Clinical Editor

No Comments

Schizophrenia is a complex and heterogenous disease that presents with abnormalities in glutamate signaling and altered immune and inflammatory signals. Genome-wide association studies have indicated …

Feb 19 2021

Uncategorized

A unique missense variant in the E1A-binding protein P400 gene is implicated in schizophrenia by whole-exome sequencing and mutant mouse models

by Clinical Editor

No Comments

This study used whole-exome sequencing to investigate potential novel schizophrenia-causing genes in a Japanese family containing several members affected by severe or treatment-resistant …

Feb 19 2021

Uncategorized

New correlation between metabolic syndrome and schizophrenia

by Clinical Editor

No Comments

Medics have been seeking to understand why schizophrenia and bipolar disorder patients, prescribed antipsychotic medications, often rapidly gain weight (which can lead to prediabetes). New research …

Feb 19 2021

Uncategorized

We Need To Talk About the Potential Link Between COVID-19 and Schizophrenia

by Clinical Editor

No Comments

Neuroscience student Brian Fu discusses recent research that suggests a potential link between mortality due to the coronavirus (COVID-19) and schizophrenia or associated spectrum disorders.